Synapse - Alison Moskowitz

Results (83)

Phase II trial of nivolumab plus doxorubicin, vinblastine, dacarbazine as frontline therapy in older adults with Hodgkin lymphoma

Journal Article

Torka, P.; Feldman, T.; Savage, K. J.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Capadona, C.; Subzwari, S.; more...
Journal of Clinical Oncology (2025)

Fulltext@MSK | Save

Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: Real-life experience

Journal Article

Cassanello, G.; Drill, E.; Rivas-Delgado, A.; Okwali, M.; Isgor, I.; Caron, P. C.; Epstein-Peterson, Z.; Ghione, P.; Hamlin, P. A.; Lue, J. K.; more...
Haematologica (2025)

Fulltext@MSK | Save

Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutation

Journal Article

Kumar, A.; Soumerai, J.; Abramson, J. S.; Barnes, J. A.; Caron, P.; Chhabra, S.; Chabowska, M.; Dogan, A.; Falchi, L.; Grieve, C.; more...
Blood (2025)

Fulltext@MSK | Save

Final response and survival results from a phase II trial of pembrolizumab and entinostat in relapsed/refractory Hodgkin lymphoma

Meeting Abstract

Stuver, R.; Vardhana, S. A.; Ganesan, N.; Boardman, A. P.; Caron, P.; Chang, T.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; more...
Blood (2024)

Fulltext@MSK | Save

Brentuximab vedotin-based regimens for older patients with newly diagnosed classical Hodgkin lymphoma - International, multi-center real-world experience

Meeting Abstract

Luttwak, E.; Kambhampati, S.; Drill, E.; Ganesan, N.; Hofstetter, L.; Gurion, R.; Aumann, S.; Haran, A.; Geva, M.; Panossian, M.; more...
Blood (2024)

Fulltext@MSK | Save

Global response score correlates with quality of life in cutaneous T-cell lymphoma

Meeting Abstract

Khan, N.; Drill, E.; Moskowitz, A.; Shinohara, M.; Larocca, C.; Querfeld, C.; Zain, J.; Horwitz, S.
Quality of Life Research (2024)

Fulltext@MSK | Save

Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: A phase 1b/2a trial

Journal Article

Horwitz, S. M.; Nirmal, A. J.; Rahman, J.; Xu, R.; Drill, E.; Galasso, N.; Ganesan, N.; Davey, T.; Hancock, H.; Perez, L.; more...
Nature Medicine (2024)

Fulltext@MSK | Save

BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation

Research Letter

Stuver, R.; Mian, A.; Brown, S.; Devlin, S.; Caimi, P. F.; Chinapen, S.; Dahi, P.; Dean, R.; Epstein-Peterson, Z. D.; Hill, B.; more...
American Journal of Hematology (2024)

Fulltext@MSK | Save

Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation

Journal Article

Epstein-Peterson, Z. D.; Drill, E.; Aypar, U.; Batlevi, C. L.; Caron, P.; Dogan, A.; Drullinsky, P.; Gerecitano, J.; Hamlin, P. A.; Ho, C.; more...
Haematologica (2024)

Fulltext@MSK | Save

Outcomes for patients with classical Hodgkin lymphoma who relapse after autologous stem cell transplant in the era of novel therapies

Meeting Abstract

Stuver, R.; Drill, E.; Ganesan, N.; Baron, K.; Casper, E.; Chang, T.; Desai, S. H.; Falade, A. S.; Galasso, N.; Herrera, A. F.; more...
Blood (2023)

Fulltext@MSK | Save